Skip to content

Analysis of the selection of treatment plans for acute acquired concomitant esotropia (AACE) and the influencing factors related to prognosis

Analysis of the selection of treatment plans for acute acquired concomitant esotropia (AACE) and the influencing factors related to prognosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116353
Enrollment
Unknown
Registered
2026-01-08
Start date
2026-01-28
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute acquired concomitant esotropia (AACE)

Interventions

BTX-A Group:None

Sponsors

The Second Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1: The diagnosis was clearly confirmed as acute acquired concomitant esotropia (AACE); 2: Patients who have undergone surgical treatment or received botulinum toxin injection for the extraocular muscles;

Exclusion criteria

Exclusion criteria: 1: Those who suffer from severe systemic diseases such as systemic infection, autoimmune disorders, and renal insufficiency; 2: Those with indications of intracranial lesions as suggested by imaging examinations; 3: There was a clear history of head or eye trauma within 3 months prior to the onset of the disease.

Design outcomes

Primary

MeasureTime frame
Strabismus degree;

Countries

China

Contacts

Public ContactQianqian Wan

The Second Hospital of Anhui Medical University

wanqianqian0802@126.com+86 139 5698 5387

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026